Nextracker (NASDAQ:NXT – Get Free Report) will likely be releasing its Q2 2026 results after the market closes on Thursday, October 23rd. Analysts expect Nextracker to post earnings of $0.98 per share and revenue of $839.5320 million for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earningresults page for the latest details on the call scheduled for Thursday, October 23, 2025 at 5:00 PM ET.
Nextracker Trading Up 7.1%
Shares of NASDAQ:NXT opened at $93.12 on Thursday. Nextracker has a 12 month low of $30.93 and a 12 month high of $93.50. The company has a market cap of $13.78 billion, a price-to-earnings ratio of 25.37, a price-to-earnings-growth ratio of 2.15 and a beta of 2.27. The company has a 50-day moving average price of $69.93 and a 200-day moving average price of $58.91.
Insider Activity
In other Nextracker news, President Howard Wenger sold 5,217 shares of the firm’s stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $75.00, for a total transaction of $391,275.00. Following the completion of the sale, the president directly owned 409,039 shares in the company, valued at approximately $30,677,925. This trade represents a 1.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Bruce Ledesma sold 6,980 shares of Nextracker stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $56.24, for a total transaction of $392,555.20. Following the completion of the transaction, the insider directly owned 195,790 shares of the company’s stock, valued at $11,011,229.60. This trade represents a 3.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 32,400 shares of company stock valued at $2,053,385. Company insiders own 0.56% of the company’s stock.
Hedge Funds Weigh In On Nextracker
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the stock. Bank of America increased their price target on shares of Nextracker from $66.00 to $69.00 and gave the stock a “buy” rating in a research note on Wednesday, July 30th. Susquehanna increased their price target on shares of Nextracker from $76.00 to $100.00 and gave the stock a “positive” rating in a research note on Monday. Zacks Research raised shares of Nextracker to a “hold” rating in a research note on Tuesday, August 12th. The Goldman Sachs Group increased their price target on shares of Nextracker from $79.00 to $89.00 and gave the stock a “buy” rating in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company increased their price target on shares of Nextracker from $71.00 to $72.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 30th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $70.35.
Check Out Our Latest Stock Analysis on Nextracker
About Nextracker
Nextracker Inc, an energy solutions company, provides solar tracker and software solutions for utility-scale and distributed generation solar projects in the United States and internationally. The company offers tracking solutions, which includes NX Horizon, a solar tracking solution; and NX Horizon-XTR, a terrain-following tracker designed to expand the addressable market for trackers on sites with sloped, uneven, and challenging terrain.
Read More
- Five stocks we like better than Nextracker
- What Are the U.K. Market Holidays? How to Invest and Trade
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 3 Small Caps With Big Return Potential
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Nextracker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextracker and related companies with MarketBeat.com's FREE daily email newsletter.